MRL Ventures Fund
Finance · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
320 Bent St Fl 4, Cambridge, Massachuset...Phone Number
(908) 423-1000Website
www.mrlv.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About MRL Ventures Fund
MRL Ventures Fund (MRLV) is a therapeutics-focused corporate venture group that partners with visionary founders to invest in early-stage, preclinical therapeutics companies globally. The fund provides capital, strategic guidance, and access to MSD's expertise to accelerate the development of breakthrough therapeutics aimed at transforming patient care. MRLV focuses on first-in-class therapeutic innovations across various modalities, supporting companies from initial investment through key development milestones. With a commitment to long-term partnerships, MRLV emphasizes a science-driven approach to investing, prioritizing patient impact and transformative medical practices.Explore more
MRL Ventures Fund Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MRL Ventures Fund your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once MRL Ventures Fund has new funding data
Website visits: Recent activity has been detected on your website
Check out if MRL Ventures Fund is spiking on competitors!
Check if MRL Ventures Fund has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on MRL Ventures Fund recently announced quarterly report
Product Launch: Get notified when MRL Ventures Fund launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
MRL Ventures Fund, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at MRL Ventures Fund
Click to see if MRL Ventures Fund had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at MRL Ventures Fund
Find 3 more new buyers
Compare Similar Companies to MRL Ventures Fund
Compare insights from companies similar to MRL Ventures Fund, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MRL Ventures Fund is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
MRL Ventures Fund is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about MRL Ventures Fund.
MRL Ventures Fund Tech Stack
A closer look at the technologies used by MRL Ventures Fund
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
MRL Ventures Fund News & Media
InduPro Announces $85 Million Series A Financing, Appoints Prakash Raman, Ph.D. as CEO to Advance Next-Generation, Proximity-Based Protein Therapeutics for the Treatment of Cancer and Autoimmune Diseases
Developing therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies Series A proceeds fund advancement of the Company's lead programs to clinical readiness and the identification of additional candidates Dr. Raman, a seasoned industry veteran...Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in-Class Membrane-Permeable Macrocyclic Peptides
BERKELEY, Calif.--(BUSINESS WIRE)--Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures to Develop Best-in-Class Membrane-Permeable Macrocyclic PeptidesEyeBio Raises $65M in Series A Funding to Develop New Generation of Eye Disease Therapies
LONDON & NEW YORK--(BUSINESS WIRE)--Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases, today announced the completion of a successful $65 million Series A funding round. SV Health Investors led the round, alongside Samsara BioCapital and Jeito Capital, with additional financial backing from MRL Ventures. The Series A brings together an international team of executives and investors with an extensivAmbagon Therapeutics Raises $85M in Series A Funding
Ambagon Therapeutics, a San Francisco CA-based biotechnology company, raised $85M in Series A funding. The round was led by Nextech Invest with participation from RA Capital Management, Droia Ventures, Inkef Capital, AbbVie Ventures, MRL Ventures Fund, and Mission BioCapital and new investor Surveyor Capital (a Citadel company). The company intends to use the funds to […] The post Ambagon Therapeutics Raises $85M in Series A Funding appeared first on FinSMEs.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MRL Ventures Fund
Sign Up For FreeTo access detailed company insights
MRL Ventures Fund (MRLV) is a therapeutics-focused corporate venture group that partners with visionary founders to invest in early-stage, preclinical therapeutics companies globally. The fund provides capital, strategic guidance, and access to MSD's expertise to accelerate the development of breakthrough therapeutics aimed at transforming patient... Read More
